Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence

Several immunotherapy agents are the standard of care of many solid malignancies. Nevertheless, the majority of patients do not benefit from the currently available immunotherapies. It is therefore of paramount importance to identify the prognostic and predictive factors of tumor response/resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirabile, Aurora, Rivoltini, Licia, Daveri, Elena, Vernieri, Claudio, Mele, Roberto, Porcu, Luca, Lazzari, Chiara, Bulotta, Alessandra, Viganò, Maria Grazia, Cascinu, Stefano, Gregorc, Vanesa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281426/
https://www.ncbi.nlm.nih.gov/pubmed/32375310
http://dx.doi.org/10.3390/cancers12051153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281426/
https://www.ncbi.nlm.nih.gov/pubmed/32375310
http://dx.doi.org/10.3390/cancers12051153

Ejemplares similares